Morgan Stanley raised Eli Lilly (NYSE:LLY) price target to $448

By / / Eli Lilly, Morgan Stanley

Morgan Stanley analyst Terence Flynn maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $444 to $448.

Scroll to Top